SCN10A and hydrops fetalis: Importantly, the results of the present study demonstrate that pharmacological inhibition and genetic ablation of NaV1.8 can specifically reverse these detrimental proarrhythmic effects in the human HF heart and in our SCN10A−/−/CaMKIIδc+/T mouse model.